• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of Industry inquiries received in the month

Dictionary: The CTP Office of the Center Director receives questions and correspondence about CTP policies from all of CTP’s stakeholder groups. The Office of the Center Director’s goal is to respond to all correspondence in a timely manner. These correspondences include: general information requests, requests for technical assistance, review and comment on letters produced by the Office of the Center Director, letters expressing concerns, questions related to hearings, requests for briefings, teleconferences, videos, and documents, information provided by industry to the FDA, and responses to FDA requests for information from industry.

Information is current as of December 31, 2013

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A0
Nov 2010N/A0
Dec 2010N/A0
Jan 2011N/A20
Feb 2011N/A23
Mar 2011N/A24
Apr 2011N/A3
May 2011N/A2
Jun 2011N/A6
Jul 2011N/A24
Aug 2011N/A15
Sep 2011N/A13

FY 2011 Total: 130

Total number of Industry inquiries responded to in the month

Dictionary: The CTP Office of the Center Director receives questions and correspondence about CTP policies from all of CTP’s stakeholder groups. The Office of the Center Director’s goal is to respond to all correspondence in a timely manner. These correspondences include: general information requests, requests for technical assistance, review and comment on letters produced by the Office of the Center Director, letters expressing concerns, questions related to hearings, requests for briefings, teleconferences, videos, and documents, information provided by industry to the FDA, and responses to FDA requests for information from industry.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeTargetNumber
Oct 2010N/A0
Nov 2010N/A0
Dec 2010N/A0
Jan 2011N/A16
Feb 2011N/A16
Mar 2011N/A17
Apr 2011N/A16
May 2011N/A14
Jun 2011N/A18
Jul 2011N/A16
Aug 2011N/A10
Sep 2011N/A12

FY 2011 Total: 135

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.